-
Basiliximab, sold
under the
brand name Simulect, is a
monoclonal antibody used to
prevent rejection in
kidney transplants. It is a
chimeric mouse-human...
-
ankylosing spondylitis by
their ability to bind to and
inhibit TNF-α.
Basiliximab and
daclizumab inhibit IL-2 on
activated T
cells and
thereby help prevent...
-
Barstatin 100
barucainide (INN)
barusiban (INN)
Basaljel basifungin (INN)
basiliximab (INN)
batabulin (USAN)
batanopride (INN)
batebulast (INN) batelapine...
- antibodies, are also used in
these conditions and
include rituximab,
basiliximab and eculizumab.
Blood products including intravenous immunoglobulin and...
- antagonists,
tyrosine kinase inhibitors, beta-glycan peptides, halofuginone,
basiliximab, alemtuzumab, abatacept, and
haematopoietic stem cell transplantation...
-
presentation of two
chimeric mouse/human anti-Tac
antibodies in the year 1998:
basiliximab (Simulect) and
daclizumab (Zenapax).
These drugs act by
binding the IL-2a...
-
pegol L04AB06
Golimumab L04AB07
Opinercept L04AC01
Daclizumab L04AC02
Basiliximab L04AC03
Anakinra L04AC04
Rilonacept L04AC05
Ustekinumab L04AC07 Tocilizumab...
-
Interleukin 2
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies:
Basiliximab Daclizumab (dacliximab)
Inolimomab IL-3 Agonists:
Daniplestim Interleukin...
-
chimeric antibodies approved for
human therapy include abciximab (ReoPro),
basiliximab (Simulect),
cetuximab (Erbitux),
infliximab (Remicade) and rituximab...
-
severe damage to the graft. Anti-IL-2Rα
receptor antibodies such as
basiliximab and
daclizumab are
increasingly being used in
place of ATG as an induction...
